Low molecular weight heparin in prophylaxis of deep vein thrombosis in Asian general surgical patients: A Kashmir experience
Open Access
- 1 April 2012
- journal article
- research article
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 16 (2) , 71-74
Abstract
Background and Objectives: Deep vein thrombosis (DVT) occurs at a lower rate in Asia than in the rest of the world. We wanted to study the significance and efficacy of low molecular weight heparin (LMWH) in prophylaxis of DVT in major general surgical patients in the Kashmir Valley (India, Asia) so as to make it a routine in our patients. Patients and Methods: This was a prospective study in which the effect of LMWH was compared with no prophylaxis. Results: LMWHs are more effective than no prophylaxis in the prevention of DVT and pulmonary thromboembolism in highest-risk general surgical patients (odds ratio = 16.64; 95% confidence interval = 3.63-1130.03; P-value = 0.014). Conclusion: LMWHs have a significant prophylactic effect on DVT in general surgical patients, with a higher benefit to risk ratio, and, in spite of the low incidence of DVT in Asia, its prophylaxis should routinely be considered in this part of the world as well, preferably in the form of LMWHs.Keywords
This publication has 23 references indexed in Scilit:
- A Systematic Review of Deep Venous Thrombosis Prophylaxis in Cancer Patients: Implications for Improving QualityAnnals of Surgical Oncology, 2006
- Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic diseaseSeminars in Hematology, 2001
- Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic diseaseSeminars in Hematology, 2001
- Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessmentBritish Journal of Surgery, 1997
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.BMJ, 1992
- Prevention of venous thromboembolism after surgery: A review of enoxaparinBritish Journal of Surgery, 1992
- Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosisBritish Journal of Surgery, 1988
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- Prophylaxis of deep venous thrombosis in colorectal surgeryDiseases of the Colon & Rectum, 1982